a 63162 has been researched along with sodium salicylate in 1 studies
Studies (a 63162) | Trials (a 63162) | Recent Studies (post-2010) (a 63162) | Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) |
---|---|---|---|---|---|
31 | 0 | 0 | 2,031 | 50 | 171 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrlich, K; Peskar, BA; Peskar, BM; Schuligoi, R | 1 |
1 other study(ies) available for a 63162 and sodium salicylate
Article | Year |
---|---|
Role of lipoxygenases and lipoxin A(4)/annexin-1 receptor in gastric protection induced by 20% ethanol or sodium salicylate in rats.
Topics: Acetamides; Animals; Annexins; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Drug Interactions; Ethanol; Flavanones; Fluorenes; Gastric Mucosa; Glucocorticoids; Lipoxygenase; Lipoxygenase Inhibitors; Male; Oligopeptides; Phenyl Ethers; Prostaglandin Antagonists; Pyrazoles; Rats; Rats, Wistar; Receptors, Formyl Peptide; Receptors, Lipoxin; Reperfusion Injury; Sodium Salicylate; Sulfonamides | 2009 |